Subscriptions include print and electronic issues
Pub Code: NDBN-11WEB
A hard-hitting newsletter for health plans, PBMs, pharma companies and employers. Published biweekly, it delivers both timely news stories and in-depth accounts of cost management strategies that are being employed by drug purchasers. Coverage includes up-to-the minute news of industry consolidation, strategies for participation in exchanges, generic promotion tactics, formulary decisions, innovative benefit designs, drug pricing methodologies, PBM contracting, changes in Part D and other federal initiatives, and much more.
With so much at stake in the pharmaceutical business, you need a clear picture of the challenges and opportunities ahead. Rely on Drug Benefit News — a biweekly newsletter focused exclusively on the business of pharmacy benefit management — to provide details of the most notable, effective strategies for managing:
With in-depth accounts of cost management strategies, Drug Benefit News takes in-the-field approaches and presents them alongside guidance from experts across the nation in key areas, such as:
As a subscriber to Drug Benefit News, you receive:
Rely on Drug Benefit News for timely news and data on the business of pharmaceuticals ... and get practical cost management strategies from experts throughout the industry. Subscribe today!
Drug Benefit News is written by an editorial team with extensive experience in pharma/health care business publishing. Editor Lauren Flynn Kelly, who served as editor of DBN from 2004 to 2005 and returned to AIS in 2011, has been covering health business issues for more than a decade. Managing Editor Angela Maas has an extensive background in editing, reporting and writing for both trade and consumer publications. Angela also is the managing editor of AIS’s Web and email news content, and the monthly newsletter Specialty Pharmacy News. Executive Editor Jill Brown is a veteran health care reporter who brings an intelligent perspective on the forces reshaping the health care industry.
When you subscribe to Drug Benefit News, your satisfaction is fully guaranteed. If you are not completely satisfied with the newsletter within the first 30 days, just cancel and receive a prompt 100% refund. After your first 30 days, you may cancel at any time in the year ahead and receive a full prompt refund for all unmailed issues.
Electronic (PDF) versions of the newsletter are available, on the newsletter’s subscriber-only Web page, on the day of publication. Recipients should whitelist email@example.com to ensure delivery of the e-mail notification of new issues. Print newsletters are mailed 1st class through the U.S. Postal Service. You should receive your first issue within 5-7 business days of your order. A one-time $12 shipping and handling charge will be applied to your order.
Renew your subscriptions to AIS newsletters and looseleaf publications at the Renewal Center